Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N03AX12	GABATREX	G	Gabapentin - 300mg	300mg	Capsule	1,585,734 L.L
C09CA04	GIZLAN	G	Irbesartan - 300mg	300mg	Tablet, film coated	768,678 L.L
G03GA05	GONAL-f	BioHuman	Follitropin alfa - 300IU/0.5ml	300IU/0.5ml	Injectable solution	10,305,698 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 6g/20ml	30%	Injectable solution	5,157,668 L.L
L02AE04	GONAPEPTYL CR	B	Triptorelin - 3.75mg	3.75mg	Injectable powder for suspension+diluent	12,095,730 L.L
A10BB12	GLIM	G	Glimepiride - 2mg	2mg	Tablet	401,809 L.L
A10BB12	GLUMYL 2	G	Glimepiride - 2mg	2mg	Tablet	189,418 L.L
A10BB12	GLYPRIDE	G	Glimepiride - 2mg	2mg	Tablet	403,153 L.L
N02BF02	GABRIKA 25	G	Pregabalin - 25mg	25mg	Capsule	560,062 L.L
N02BF02	GABRIKA 25	G	Pregabalin - 25mg	25mg	Capsule	341,720 L.L
L01EB01	GEFITINIB ARROW	G	Gefitinib - 250mg	250mg	Tablet, coated	85,330,070 L.L
L01EB01	GEFITINIB BIOGARAN	G	Gefitinib - 250mg	250mg	Tablet, coated	87,070,893 L.L
L01EB01	GEFITINIB BIOGARAN	G	Gefitinib - 250mg	250mg	Tablet, coated	L.L
L01EB01	GEFITINIB ARROW	G	Gefitinib - 250mg	250mg	Tablet, coated	L.L
L03AX13	GLITAXON	G	Glatiramer acetate - 20mg/ml	20mg/ml	Injectable solution	10,146,988 L.L
A02BC01	GASTRAZOLE	G	Omeprazole - 20mg	20mg	Capsule	185,450 L.L
A02BC01	GASTRIMUT	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	427,342 L.L
A02BC01	GASTRIMUT	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	6,720,556 L.L
A02BC01	GASTRISEC	G	Omeprazole - 20mg	20mg	Capsule	413,903 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, enteric coated	568,445 L.L
L01BC05	GEMCITABIN EBEWE	G	Gemcitabine (HCl) - 200mg/20ml	200mg/20ml	Injectable concentrated solution	2,121,927 L.L
G01AF04	GYNO-MIKOZAL	G	Miconazole nitrate - 200mg	200mg	Ovule	503,941 L.L
L01BC05	GEMCITABINE NEAPOLIS	G	Gemcitabine (HCl) - 200mg	200mg	Injectable powder for solution	1,490,321 L.L
L01BC05	GEMCITABINE THYMOORGAN	G	Gemcitabine (HCl) - 200mg	200mg	Injectable powder for solution	1,617,986 L.L
L01BC05	GEMNIL	G	Gemcitabine (HCl) - 200mg	200mg	Injectable powder for solution	1,128,828 L.L
L01BC05	GEMTABINE 200	G	Gemcitabine HCl - 200mg	200mg	Injectable lyophilised powder for solution	1,343,843 L.L
L01BC05	GEMCITABINE THYMOORGAN	G	Gemcitabine (HCl) - 200mg	200mg	Injectable powder for solution	L.L
A04AA02	GRANI-DENK	G	Granisetron - 1mg/ml	1mg/ml	Injectable concentrate for solution	893,655 L.L
A10BB12	GLIM	G	Glimepiride - 1mg	1mg	Tablet	302,365 L.L
A10BB12	GLUMYL 1	G	Glimepiride - 1mg	1mg	Tablet	186,858 L.L